I shook my head last year when Yahoo! first reported the relationship between Marlon Byrd and former BALCO bad boy and “cream” and “clear” creator Victor Conte. The upshot: Conte supplies Byrd with all manner of supplements, the identity and nature of which Byrd has only the vaguest notions. Byrd was then and remains today the only Major League Baseball player who works with Conte.
Yahoo!’s Steve Henson updates the story today and not much has changed. We do learn, however, that after last year’s story came out Major League Baseball went ballistic at one of its players working with Conte and demanded a meeting with Byrd over it all. That never happened, apparently because MLB realized that Byrd (a) hadn’t failed any drug tests; (b) has always been a good baseball citizen; and (c) was still an American citizen with some freakin’ rights, dadgummit.
My head-shaking over it all wasn’t (and still isn’t) inspired the same thing that sparked Major League Baseball’s ire — the mere association with Conte — my thing was Byrd’s seemingly total trust in the guy. In last year’s story Byrd said he never even asks what’s in the supplements he’s given by Conte, and there is no indication in today’s article that he’s acquired any additional curiosity.
And, hell, now that I think about it, maybe it’s better that he’s going through Conte than diving into the supplement world himself. As we’ve learned in recent years, a large number of over-the-counter supplements contained banned substances, many of which aren’t even listed on the label. It would be easy for someone to mess up and take a banned substance. At least Conte has (a) expertise; and (b) the motive to grow his business from its post-BALCO ashes. He knows that if one of his athletes test positive for something he’s beyond ruined.
But even if I don’t subscribe to the idea of guilt by association, it is rather amazing to me that a ballplayer would associate with Conte in this day and age. I like Byrd so I hope it doesn’t burn him, but man, I don’t know that I’d take that chance.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.
Jon Morosi of FOX Sports reports that free agent reliever Joe Nathan, recovering from Tommy John surgery, plans to pitch in 2016 according to his agent Dave Pepe. According to Pepe, Nathan’s workouts are “going well” and the right-hander is “definitely planning on playing this year.”
Nathan, 41, got the final out on Opening Day (April 6) against the Twins before going on the disabled list with a flexor strain in his right elbow, causing him to miss the next 161 games. He will likely be able to contribute out of the bullpen in late May or early June if he has no setbacks. On a minor league deal or incentive-laden major league deal, Nathan could make for a low-risk gamble.
Over a 15-season career that dates back to 1999 (he did not pitch in the majors in 2001 or 2010), Nathan has 377 saves with a 2.89 ERA and a 967/340 K/BB ratio over 917 innings.
On Thursday, we learned that the Diamondbacks were still considering free agent reliever Tyler Clippard. You can add the Rays to the list as well, per Marc Topkin of the Tampa Bay Times.
The Rays traded lefty reliever Jake McGee to the Rockies in exchange for outfielder Corey Dickerson in late January, so Clippard would be able to slot right in behind closer Brad Boxberger. Clippard, 30, compiled a 2.92 ERA with 64 strikeouts and 31 walks over 71 innings in a season split between the Athletics and Mets. The strikeout rate was at its lowest since the right-hander become a full-time reliever in 2009, and his walk rate was at its highest since 2010, which may be a factor in his still being a free agent in February.